Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. HMO Market Segmentation on the basis of Type
8.1 2’ Fl
8.2 3’ Fl
8.3 3’ Sl
8.4 6’ Sl
9. HMO Market Segmentation on the basis of Application
9.1 Infant Formula
9.2 Functional Food & Beverages
9.3 Food Supplement
10. HMO Market Segmentation on the basis of Concentration
10.1 Acidic
10.2 Neutral
11. HMO Market Segmentation on the basis of distribution channel,
11.2 Hypermarkets and supermarkets
11.3 Drug stores or pharmacy
11.4 Mass merchandiser
11.5 Departmental stores
11.6 Mono-brand stores
11.7 Specialty stores
11.8 Online sales channel
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 BASF S.E.
13.3 Biosynth Carbosynth
13.4 Chr. Hansen Holding A/S
13.5 Dextra Laboratories Ltd.
13.6 Dupont Nutrition & Biosciences
13.7 Elicityl S.A.
13.8 Glycom A/S
13.9 Glycosyn
13.10 Inbiose N
13.11 Medolac Laboratories
13.12 Neolacta Lifesciences Pvt. Ltd
13.13 Nestle Health Science
13.13 Royal DSM
13.15 ZuChem
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share analysis
15.3 Recent Developments
16. Conclusion
